Quan L - Search Results

1

[Grading standard of processed Curcumae Radix].

Chen ZM, Quan L, Zhou HT, Zhao YF, Wang L, Xiong HJ, Hu CJ, Li WB. Chen ZM, et al. Among authors: quan l. Zhongguo Zhong Yao Za Zhi. 2018 Nov;43(22):4450-4456. doi: 10.19540/j.cnki.cjcmm.20180807.002. Zhongguo Zhong Yao Za Zhi. 2018. PMID: 30593237 Chinese.

2

Study on Quality Standard of Processed Curcuma Longa Radix.

Chen Z, Zhao Y, Quan L, Zhou H, Cao D, Hu C, Li W, Yang Z. Chen Z, et al. Among authors: quan l. Evid Based Complement Alternat Med. 2017;2017:2830754. doi: 10.1155/2017/2830754. Epub 2017 Dec 11. Evid Based Complement Alternat Med. 2017. PMID: 29375640 Free PMC article.

3

The Effects of Curcumae Longae Radix, Curcuma phaeocaulis Radix and Their Processed Products on Epo/EpoR Pathway and CD62p.

Chen Z, Li W, Quan L, Zhou H, Zhao Y, Zhang X, Hu L, Hu C. Chen Z, et al. Among authors: quan l. Front Pharmacol. 2018 Jul 9;9:736. doi: 10.3389/fphar.2018.00736. eCollection 2018. Front Pharmacol. 2018. PMID: 30038572 Free PMC article.

4

Screening of active fractions from Curcuma Longa Radix isolated by HPLC and GC-MS for promotion of blood circulation and relief of pain.

Chen Z, Quan L, Zhou H, Zhao Y, Chen P, Hu L, Yang Z, Hu C, Cao D. Chen Z, et al. Among authors: quan l. J Ethnopharmacol. 2019 Apr 24;234:68-75. doi: 10.1016/j.jep.2018.09.035. Epub 2018 Sep 27. J Ethnopharmacol. 2019. PMID: 30268652

5

[GC-MS analysis of essential oil from pericarp of Illicium modestum A. C. Smith].

Huang J, Wang J, Yang C, Wang H, Quan L, Zhang X, Cao H. Huang J, et al. Among authors: quan l. Zhongguo Zhong Yao Za Zhi. 1996 Mar;21(3):168-70, 191. Zhongguo Zhong Yao Za Zhi. 1996. PMID: 9206259 Chinese.

6

Prognostic value of the FUT family in acute myeloid leukemia.

Dai Y, Cheng Z, Pang Y, Jiao Y, Qian T, Quan L, Cui L, Liu Y, Si C, Chen J, Ye X, Chen J, Shi J, Wu D, Zhang X, Fu L. Dai Y, et al. Among authors: quan l. Cancer Gene Ther. 2020 Feb;27(1-2):70-80. doi: 10.1038/s41417-019-0115-9. Epub 2019 Jun 17. Cancer Gene Ther. 2020. PMID: 31209266

7

Prognostic significance of PAK family kinases in acute myeloid leukemia.

Quan L, Cheng Z, Dai Y, Jiao Y, Shi J, Fu L. Quan L, et al. Cancer Gene Ther. 2020 Feb;27(1-2):30-37. doi: 10.1038/s41417-019-0090-1. Epub 2019 Mar 20. Cancer Gene Ther. 2020. PMID: 30890765

8

Emerging agents and regimens for treatment of relapsed and refractory acute myeloid leukemia.

Cui L, Liu Y, Pang Y, Qian T, Quan L, Cheng Z, Dai Y, Ye X, Pang Y, Shi J, Ke X, Wu D, Fu L. Cui L, et al. Among authors: quan l. Cancer Gene Ther. 2020 Feb;27(1-2):1-14. doi: 10.1038/s41417-019-0119-5. Epub 2019 Jul 11. Cancer Gene Ther. 2020. PMID: 31292516 Review.

9

Prognostic role of minichromosome maintenance family in multiple myeloma.

Quan L, Qian T, Cui L, Liu Y, Fu L, Si C. Quan L, et al. Cancer Gene Ther. 2020 Nov;27(10-11):819-829. doi: 10.1038/s41417-020-0162-2. Epub 2020 Jan 21. Cancer Gene Ther. 2020. PMID: 31959909

10

Prognostic role of SCAMP family in acute myeloid leukemia.

Qian T, Cheng Z, Quan L, Zeng T, Cui L, Liu Y, Si C, Huang W, Dai Y, Chen J, Liu L, Jiao Y, Deng C, Pang Y, Ye X, Shi J, Fu L. Qian T, et al. Among authors: quan l. Pharmacogenomics J. 2020 Aug;20(4):595-600. doi: 10.1038/s41397-020-0149-2. Epub 2020 Jan 28. Pharmacogenomics J. 2020. PMID: 31988488

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

916 results

Search Page